Re: Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
(Source: BMJ Comments)
Source: BMJ Comments - November 24, 2023 Category: General Medicine Source Type: forums
What Do You Think Of Pharmacogenomics to Restrict Statins Prescriptions?
In my humble opinion Statins is a Multi Billion Dollars Business, and are mostly prescribed for low risk patients with huge and huge NNTs for clinical benefits.
Now, a recent Article suggest Genotype based polymorphisms can be a good guide for Statins Prescriptions. As usual with any statin positive results it is being heavily advertised.
They Do Not mention Epigenetics which can change completely any genetic background under different environment circunstances.
What Do You GuysThink?
Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentration in Routine Clinica...
Source: Doc2Doc BMJ Cardiology - August 19, 2013 Category: Cardiology Authors: Joey Rio Source Type: forums
above and beyond for customers
I'm a technician at my pharmacy I work at (its a retail chain) and I often find myself being the only person actually trying to help a customer out with a prescription cost. Mainly with name brand prescription drugs like crestor, tradjenta, viagra, lunesta, azor, etc..... Most of the people who take these are older and have medicare or some sort of HMO from medicare and for the most part their prescriptions are covered for a good amount of the cost, but then they fall into the dreaded donut hole. "Oh hi sir, coming to get you Tradjenta? Ok it will be $265. Patient: WHATTTT? I paid $15 for the last 6 months?"
...
Source: Student Doctor Network Forums - June 16, 2013 Category: Universities & Medical Training Authors: Tonyg89 Tags: Pharmacy Source Type: forums
